Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Femasys Inc. (FEMY)

1.085   -0.105 (-8.82%) 03-31 15:52
Open: 1.04 Pre. Close: 1.19
High: 1.1 Low: 1.04
Volume: 12,127 Market Cap: 13(M)

Technical analysis

as of: 2023-03-31 4:18:39 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.41     One year: 1.68
Support: Support1: 0.83    Support2: 0.69
Resistance: Resistance1: 1.21    Resistance2: 1.44
Pivot: 1.12
Moving Average: MA(5): 1.16     MA(20): 1.13
MA(100): 1.14     MA(250): 1.46
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 71.7     %D(3): 69.9
RSI: RSI(14): 45.8
52-week: High: 2.97  Low: 0.56
Average Vol(K): 3-Month: 15 (K)  10-Days: 15 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ FEMY ] has closed above bottom band by 42.6%. Bollinger Bands are 45.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.25 - 1.26 1.26 - 1.26
Low: 1.09 - 1.1 1.1 - 1.11
Close: 1.14 - 1.15 1.15 - 1.16

Company Description

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Headline News

Fri, 31 Mar 2023
Chardan Capital Maintains Buy Rating for Femasys: Here's What ... - Benzinga

Fri, 31 Mar 2023
Our Exclusive Articles - Benzinga

Thu, 30 Mar 2023
Femasys Inc. Announces Financial Results for the Year Ended ... - GlobeNewswire

Thu, 16 Mar 2023
Why Titan Machinery Shares Are Trading Lower By Around 18 ... - UK

Thu, 09 Mar 2023
Femasys Inc. to Participate in “The Post-Roe Fertility Journey” Panel Discussion at SXSW 2023 - Yahoo Finance

Mon, 19 Dec 2022
Femasys Inc. Announces Commercial Availability of its FemCath ... - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 12 (M)
Shares Float 9 (M)
% Held by Insiders 19 (%)
% Held by Institutions 8.5 (%)
Shares Short 7 (K)
Shares Short P.Month 14 (K)

Stock Financials

EPS -0.88
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.51
Profit Margin (%) 0
Operating Margin (%) -893.6
Return on Assets (ttm) -26.8
Return on Equity (ttm) -46.6
Qtrly Rev. Growth 28.8
Gross Profit (p.s.) 0.06
Sales Per Share 0.1
EBITDA (p.s.) -0.88
Qtrly Earnings Growth 0
Operating Cash Flow -10 (M)
Levered Free Cash Flow -6 (M)

Stock Valuations

PE Ratio -1.24
PEG Ratio 0
Price to Book value 0.71
Price to Sales 10.46
Price to Cash Flow -1.28

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.